Phosphate toxicity: New insights into an old problem

Clinical Science

Volumn 120, Issue 3, 2011, Pages 91-97

  Razzaque, M Shawkat ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Calcium; Fibroblast growth factor 23 (FGF23); Klotho; Parathyroid hormone (PTH); Sodium dependent phosphate transporter; Vitamin D

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D;

HYPERPHOSPHATEMIA; PHOSPHATE BALANCE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; TOXICITY;

ANIMALS; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HOMEOSTASIS; HUMANS; PHOSPHATES;

EID: 78650668099     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100377     Document Type: Review

References (79)

1. Fukagawa, M., Hamada, Y., Nakanishi, S. and Tanaka, M. (2006) The kidney and bone metabolism: nephrologists' point of view. J. Bone Miner. Metab. 24, 434-438
2. Laroche, M. and Boyer, J. F. (2005) Phosphate diabetes, tubular phosphate reabsorption and phosphatonins. J. Bone Spine 72, 376-381
3. Huttunen, M. M., Pietila, P. E., Viljakainen, H. T. and Lamberg-Allardt, C. J. (2006) Prolonged increase in dietary phosphate intake alters bone mineralization in adult male rats. J. Nutr. Biochem. 17, 479-484
4. Heilberg, I. P. and Weisinger, J. R. (2006) Bone disease in idiopathic hypercalciuria. Curr. Opin. Nephrol. Hypertens. 15, 394-402
5. Gaasbeek, A. and Meinders, A. E. (2005) Hypophosphatemia: an update on its etiology and treatment. Am. J. Med. 118, 1094-1101
6. Razzaque, M. S. (2009) The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat. Rev. Endocrinol. 5, 611-619
7. 31P NMR study in the human skeletal muscle. Biochem. Biophys. Res. Commun. 225, 191-194
8. 2+, and the pH gradient. Biochemistry 31, 1322-1330
9. KEGG (Kyoto Encyclopedia of Genes and Genomes) http://www.genome.jp/
10. Drezner, M. (2002) Phosphorus homeostasis and related disorders. In Principles in Bone Biology (Bilezikian, J., Raisz, L. and Rodan, G., eds), pp. 321-338, Academic Press, New York
11. Razzaque, M. S. (2009) FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am. J. Physiol. Renal Physiol. 296, F470-F476
12. Econs, M. J. (1999) New insights into the pathogenesis of inherited phosphate wasting disorders. Bone 25, 131-135
13. Miyamoto, K., Ito, M., Segawa, H. and Kuwahata, M. (2003) Molecular targets of hyperphosphataemia in chronic renal failure. Nephrol. Dial Transplant. 18 (Suppl. 3), iii79-iii80
14. Quarles, L. D. (2003) FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am. J. Physiol. Endocrinol Metab. 285, E1-E9
15. Marks, J., Debnam, E. S. and Unwin, R. J. (2010) Phosphate homeostasis and the renal-gastrointestinal axis. Am. J. Physiol. Renal. Physiol. 299, F285-F296
16. Hattenhauer, O., Traebert, M., Murer, H. and Biber, J. (1999) Regulation of small intestinal Na-Pi type IIb cotransporter by dietary phosphate intake. Am. J. Physiol. Gastrointest. Liver Physiol. 277, G756-G762
17. Sabbagh, Y., O'Brien, S. P., Song, W., Boulanger, J. H., Stockmann, A., Arbeeny, C. and Schiavi, S. C. (2009) Intestinal Npt2b plays a major role in phosphate absorption and homeostasis. J. Am. Soc. Nephrol. 20, 2348-2358
18. Corut, A., Senyigit, A., Ugur, S. A., Altin, S., Ozcelik, U., Calisir, H., Yildirim, Z., Gocmen, A. and Tolun, A. (2006) Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am. J. Hum. Genet. 79, 650-656
19. Tenenhouse, H. S. (2005) Regulation of phosphorus homeostasis by the type IIa Na/phosphate cotransporter. Annu. Rev. Nutr. 25, 197-214
20. Murer, H., Forster, I., Hilfiker, H., Pfister, M., Kaissling, B., Lotscher, M. and Biber, J. (1998) Cellular/molecular control of renal Na/Pi-cotransport. Kidney Int. Suppl. 65, S2-S10
21. Gattineni, J., Bates, C., Twombley, K., Dwarakanath, V., Robinson, M. L., Goetz, R., Mohammadi, M. and Baum, M. (2009) FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am. J. Physiol. Renal Physiol. 297, F282-F291
22. Ohnishi, M., Nakatani, T., Lanske, B. and Razzaque, M. S. (2009) In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin D levels. Circ. Cardiovasc. Genet. 2, 583-590
23. Miyamoto, K., Ito, M., Kuwahata, M., Kato, S. and Segawa, H. (2005) Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther. Apher. Dial. 9, 331-335
24. Hu, M. C., Shi, M., Zhang, J., Pastor, J., Nakatani, T., Lanske, B., Shawkat Razzaque, M., Rosenblatt, K. P., Baum, M. G., Kuro-o, M. and Moe, O. W. (2010) Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J. 24, 3438-3450
25. Keusch, I., Traebert, M., Lotscher, M., Kaissling, B., Murer, H. and Biber, J. (1998) Parathyroid hormone and dietary phosphate provoke a lysosomal routing of the proximal tubular Na/Pi-cotransporter type II. Kidney Int. 54, 1224-1232 (Pubitemid 28449909)
26. Lotscher, M., Kaissling, B., Biber, J., Murer, H. and Levi, M. (1997) Role of microtubules in the rapid regulation of renal phosphate transport in response to acute alterations in dietary phosphate content. J. Clin. Invest. 99, 1302-1312
27. Yamashita, T., Yoshioka, M. and Itoh, N. (2000) Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem. Biophys. Res. Commun. 277, 494-498
28. White, K. E., Evons, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T. and Strom, J. M. (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 26, 345-348
29. Yamashita, T. (2005) Structural and biochemical properties of fibroblast growth factor 23. Ther. Apher. Dial. 9, 313-318
30. Eswarakumar, V. P., Lax, I. and Schlessinger, J. (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139-149 (Pubitemid 40616112)
31. Mohammadi, M., Olsen, S. K. and Ibrahimi, O. A. (2005) Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16, 107-137
32. Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M. C., Moe, O. W. and Kuro-o, M. (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. 281, 6120-6123
33. Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S. and Yamashita, T. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770-774
34. Liu, S., Vierthaler, L., Tang, W., Zhou, J. and Quarles, L. D. (2008) FGFR3 and FGFR4 do not mediate renal effects of FGF23. J. Am. Soc. Nephrol. 19, 2342-2350
35. Kuro-o, M. (2006) Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr. Opin. Nephrol. Hypertens. 15, 437-441
36. Medici, D., Razzaque, M. S., Deluca, S., Rector, T. L., Hou, B., Kang, K., Goetz, R., Mohammadi, M., Kuro, O. M., Olsen, B. R. and Lanske, B. (2008) FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J. Cell Biol. 182, 459-465
37. Nabeshima, Y. (2008) The discovery of α-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis. Cell. Mol. Life Sci. 65, 3218-3230
38. Chen, C. D., Podvin, S., Gillespie, E., Leeman, S. E. and Abraham, C. R. (2007) Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc. Natl. Acad. Sci. U.S.A. 104, 19796-19801
39. Matsumura, Y., Aizawa, H., Shiraki-Iida, T., Nagai, R., Kuro-o, M. and Nabeshima, Y. (1998) Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem. Biophys. Res. Commun. 242, 626-630
40. Ohnishi, M. and Razzaque, M. S. (2010) Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J. 24, 3562-3571
41. Ohnishi, M., Nakatani, T., Lanske, B. and Razzaque, M. S. (2009) Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1α-hydroxylase. Kidney Int. 75, 1166-1172
42. Ichikawa, S., Imel, E. A., Kreiter, M. L., Yu, X., Mackenzie, D. S., Sorenson, A. H., Goetz, R., Mohammadi, M., White, K. E. and Econs, M. J. (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J. Clin. Invest. 117, 2684-2691
43. Nakatani, T., Ohnishi, M. and Razzaque, M. S. (2009) Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J. 23, 3702-3711
44. Benet-Pages, A., Orlik, P., Strom, T. M. and Lorenz-Depiereux, B. (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum. Mol. Genet. 14, 385-390
45. Nakatani, T., Bara, S., Ohnishi, M., Densmore, M. J., Taguchi, T., Goetz, R., Mohammadi, M., Lanske, B. and Razzaque, M. S. (2009) In vivo genetic evidence of klotho-dependent functions of FGF23 in regulation of systemic phosphate homeostasis. FASEB J. 23, 433-441
46. Lorenz-Depiereux, B., Bastepe, M., Benet-Pages, A., Amyere, M., Wagenstaller, J., Muller-Barth, U., Badenhoop, K., Kaiser, S. M., Rittmaster, R. S., Shlossberg, A. H. et al. (2006) DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat. Genet. 38, 1248-1250
47. DeLuca, S., Sitara, D., Kang, K., Marsell, R., Jonsson, K., Taguchi, T., Erben, R. G., Razzaque, M. S. and Lanske, B. (2008) Amelioration of the premature aging-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23. J. Pathol. 216, 345-355
48. Razzaque, M. S. (2010) Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372. Expert Opin. Ther. Pat. 20, 981-985
49. Bai, X., Dinghong, Q., Miao, D., Goltzman, D. and Karaplis, A. C. (2009) Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype. Am. J. Physiol. Endocrinol. Metab. 296, E79-E88
50. Goetz, R., Nakada, Y., Hu, M. C., Kurosu, H., Wang, L., Nakatani, T., Shi, M., Eliseenkova, A. V., Razzaque, M. S., Moe, O. W. et al. (2010) Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc. Natl. Acad. Sci. U. S. A. 107, 407-412
51. Goetz, R., Beenken, A., Ibrahimi, O. A., Kalinina, J., Olsen, S. K., Eliseenkova, A. V., Xu, C., Neubert, T. A., Zhang, F., Linhardt, R. J. et al. (2007) Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell. Biol. 27, 3417-3428
52. Lanske, B. and Razzaque, M. S. (2007) Premature aging in klotho mutant mice: cause or consequence? Ageing Res. Rev. 6, 73-79 (Pubitemid 46661813)
53. Razzaque, M. S. (2009) Does FGF23 toxicity influence the outcome of chronic kidney disease? Nephrol. Dial. Transplant. 24, 4-7
54. Razzaque, M. S. (2010) The dualistic role of vitamin D in vascular calcifications. Kidney Int., doi:10.1038/ki.2010.432
55. Razzaque, M. S. and Lanske, B. (2006) Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol. Med. 12, 298-305
56. Razzaque, M. S. and Lanske, B. (2007) The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J. Endocrinol. 194, 1-10
57. Razzaque, M. S., Sitara, D., Taguchi, T., St-Arnaud, R. and Lanske, B. (2006) Premature ageing-like phenotype in fibroblast growth factor 23 null mice is a vitamin-D mediated process. FASEB J. 20, 720-722
58. Razzaque, M. S., St-Arnaud, R., Taguchi, T. and Lanske, B. (2005) FGF-23, vitamin D and calcification: the unholy triad. Nephrol. Dial. Transplant. 20, 2032-2035
59. Voormolen, N., Noordzij, M., Grootendorst, D. C., Beetz, I., Sijpkens, Y. W., van Manen, J. G., Boeschoten, E. W., Huisman, R. M., Krediet, R. T. and Dekker, F. W. (2007) High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol. Dial. Transplant. 22, 2909-2916
60. Wang, T. J., Pencina, M. J., Booth, S. L., Jacques, P. F., Ingelsson, E., Lanier, K., Benjamin, E. J., D'Agostino, R. B., Wolf, M. et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503-511
61. Shoji, T., Shinohara, K., Kimoto, E., Emoto, M., Tahara, H., Koyama, H., Inaba, M., Fukumoto, S., Ishimura, E., Miki, T. et al. (2004) Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol. Dial. Transplant. 19, 179-184
62. Grosskopf, I., Graff, E., Charach, G., Binyamin, G., Spinrad, S. and Blum, I. (1991) Hyperphosphataemia and hypocalcaemia induced by hypertonic phosphate enema: an experimental study and review of the literature. Hum. Exp. Toxicol. 10, 351-355
63. Sotos, J. F., Cutler, E. A., Finkel, M. A. and Doody, D. (1977) Hypocalcemic coma following two pediatric phosphate enemas. Pediatrics 60, 305-307
64. Loughnan, P. and Mullins, G. C. (1977) Brain damage following a hypertonic phosphate enema. Am. J. Dis. Child. 131, 1032
65. Domico, M. B., Huynh, V., Anand, S. K. and Mink, R. (2006) Severe hyperphosphatemia and hypocalcemic tetany after oral laxative administration in a 3-month-old infant. Pediatrics 118, e1580-1583
66. Marraffa, J. M., Hui, A. and Stork, C. M. (2004) Severe hyperphosphatemia and hypocalcemia following the rectal administration of a phosphate-containing Fleet pediatric enema. Pediatr. Emerg. Care. 20, 453-456
67. Martin, R. R., Lisehora, G. R., Braxton, Jr, M. and Barcia, P. J. (1987) Fatal poisoning from sodium phosphate enema. Case report and experimental study. JAMA, J. Am. Med. Assoc. 257, 2190-2192
68. Nabeshima, Y. (2002) Klotho: a fundamental regulator of aging. Ageing Res. Rev. 1, 627-638
69. Kuro-o, M. (2001) Disease model: human aging. Trends Mol. Med. 7, 179-181
70. Nabeshima, Y. (2006) Toward a better understanding of Klotho. Sci. Aging Knowledge Environ. 2006, pe11
71. Kuro-o, M. (2010) A potential link between phosphate and aging: lessons from Klotho-deficient mice. Mech. Ageing Dev. 131, 270-275
72. Jin, H., Xu, C.-X., Lim, H.-T., Park, S.-J., Shin, J.-Y., Chung, Y.-S., Park, S.-C., Chang, S.-H., Youn, H.-J., Lee, K.-H. et al. (2009) High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling. Am. J. Respir. Crit. Care Med. 179, 59-68
73. Amato, D., Maravilla, A., Montoya, C., Gaja, O., Revilla, C., Guerra, R. and Paniagua, R. (1998) Acute effects of soft drink intake on calcium and phosphate metabolism in immature and adult rats. Rev. Invest. Clin. 50, 185-189
74. Garcia-Contreras, F., Paniagua, R., Avila-Diaz, M., Cabrera-Munoz, L., Martinez-Muniz, I., Foyo-Niembro, E. and Amato, D. (2000) Cola beverage consumption induces bone mineralization reduction in ovariectomized rats. Arch. Med. Res. 31, 360-365
75. Fernando, G. R., Martha, R. M. and Evangelina, R. (1999) Consumption of soft drinks with phosphoric acid as a risk factor for the development of hypocalcemia in postmenopausal women. J. Clin. Epidemiol. 52, 1007-1010
76. Pietsch, J. B., Shizgal, H. M. and Meakins, J. L. (1977) Injury by hypertonic phosphate enema. Can. Med. Assoc. J. 116, 1169-1170
77. Moseley, P. K. and Segar, W. E. (1968) Fluid and serum electrolyte disturbances as a complication of enemas in Hirschsprung's disease. Am. J. Dis. Child. 115, 714-718
78. Ismail, E. A., Al-Mutairi, G. and Al-Anzy, H. (2000) A fatal small dose of phosphate enema in a young child with no renal or gastrointestinal abnormality. J. Pediatr. Gastroenterol. Nutr. 30, 220-221
79. Perlman, J. M. (1997) Fatal hyperphosphatemia after oral phosphate overdose in a premature infant. Am. J. Health Syst. Pharm. 54, 2488-2490